<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>35(12)</volume><submitter>Levin A</submitter><funding>Inga-Britt and Arne Lundberg Research Foundation</funding><funding>Strategic Research Program in Diabetes at Karolinska Institutet, Center for Innovative Medicine</funding><funding>Sahlgrenska University Hospital ALF Grant</funding><funding>Swedish Kidney Foundation</funding><funding>Karolinska Institutet</funding><funding>Margaretha af Ugglas Foundation</funding><funding>AstraZeneca</funding><funding>Swedish Research Council</funding><funding>Stockholm County Council</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Diabetic nephropathy (DN) is the most common cause of end-stage renal disease, affecting ∼30% of the rapidly growing diabetic population, and strongly associated with cardiovascular risk. Despite this, the molecular mechanisms of disease remain unknown.&lt;h4>Methods&lt;/h4>RNA sequencing (RNAseq) was performed on paired, micro-dissected glomerular and tubulointerstitial tissue from patients diagnosed with DN [n = 19, 15 males, median (range) age: 61 (30-85) years, chronic kidney disease stages 1-4] and living kidney donors [n = 20, 12 males, median (range) age: 56 (30-70) years].&lt;h4>Results&lt;/h4>Principal component analysis showed a clear separation between glomeruli and tubulointerstitium transcriptomes. Differential expression analysis identified 1550 and 4530 differentially</pubmed_abstract><journal>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</journal><pagination>2059-2072</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7716805</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Novel insights into the disease transcriptome of human diabetic glomeruli and tubulointerstitium.</pubmed_title><pmcid>PMC7716805</pmcid><pubmed_authors>Levin A</pubmed_authors><pubmed_authors>Blondal T</pubmed_authors><pubmed_authors>Erlandsson F</pubmed_authors><pubmed_authors>Ebefors K</pubmed_authors><pubmed_authors>Liu P</pubmed_authors><pubmed_authors>Nordstrom J</pubmed_authors><pubmed_authors>Zambrano S</pubmed_authors><pubmed_authors>Stenvinkel P</pubmed_authors><pubmed_authors>Witasp A</pubmed_authors><pubmed_authors>Nystrom J</pubmed_authors><pubmed_authors>Wernerson A</pubmed_authors><pubmed_authors>Reznichenko A</pubmed_authors><pubmed_authors>Greasley PJ</pubmed_authors><pubmed_authors>Barany P</pubmed_authors><pubmed_authors>Patrakka J</pubmed_authors><pubmed_authors>Sorrentino A</pubmed_authors><pubmed_authors>Bruchfeld A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Novel insights into the disease transcriptome of human diabetic glomeruli and tubulointerstitium.</name><description>&lt;h4>Background&lt;/h4>Diabetic nephropathy (DN) is the most common cause of end-stage renal disease, affecting ∼30% of the rapidly growing diabetic population, and strongly associated with cardiovascular risk. Despite this, the molecular mechanisms of disease remain unknown.&lt;h4>Methods&lt;/h4>RNA sequencing (RNAseq) was performed on paired, micro-dissected glomerular and tubulointerstitial tissue from patients diagnosed with DN [n = 19, 15 males, median (range) age: 61 (30-85) years, chronic kidney disease stages 1-4] and living kidney donors [n = 20, 12 males, median (range) age: 56 (30-70) years].&lt;h4>Results&lt;/h4>Principal component analysis showed a clear separation between glomeruli and tubulointerstitium transcriptomes. Differential expression analysis identified 1550 and 4530 differentially</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Dec</publication><modification>2025-06-01T01:55:01.549Z</modification><creation>2025-06-01T01:55:01.549Z</creation></dates><accession>S-EPMC7716805</accession><cross_references><pubmed>32853351</pubmed><doi>10.1093/ndt/gfaa121</doi></cross_references></HashMap>